WarrenCapellWarren H Capell39.74389450000000-104.839435200000001225Capell, WarrenHAssociate Professorprns:coAuthorOfcoauthor ofprns:endDateend dateFaculty Rankprns:fullNamefull nameprns:grantAwardedBygrant awarded byprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:physicalNeighborOfphysical neighborprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:principalInvestigatorNameprincipal investigator nameprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:startDatestart dateprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:address2address line 2vivo:address3address line 3vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provinceAgreementvivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionGrantvivo:hasResearchArearesearch areasvivo:hasResearcherRoleresearch activitiesvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:middleNamemiddle name or initialvivo:orcidIdORCID idvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titleResearcher Rolevivo:researcherRoleOfresearcher role ofRolevivo:roleContributesTocontributes tovivo:sponsorAwardIdsponsor award idrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson24879998Abernethy AP, Capell WH, Aziz NM, Ritchie C, Prince-Paul M, Bennett RE, Kutner JSJournal of pain and symptom managementAbernethy AP, Capell WH, Aziz NM, Ritchie C, Prince-Paul M, Bennett RE, Kutner JS. Ethical conduct of palliative care research: enhancing communication between investigators and institutional review boards. J Pain Symptom Manage. 2014 Dec; 48(6):1211-21.J Pain Symptom Manage2014-05-28T00:00:002014Ethical conduct of palliative care research: enhancing communication between investigators and institutional review boards.Authorship 1211252Authorship 1202811Authorship 1202865Authorship 1202932Authorship 1202941Authorship 1204061Authorship 1204272Authorship 1204925Authorship 1205221Authorship 1205841Authorship 1209592StephenWaldoStephen W Waldo39.74515960000000-104.8406280000000010029Waldo, StephenProfessorConnieHessConnie Ng Hess39.74515960000000-104.8406280000000010518Hess, ConnieAssociate ProfessorElizabethTuptaElizabeth Tupta39.74389450000000-104.8394352000000011067Tupta, ElizabethAsst ProfessorAuthorship 156952728135830Daddato A, Wald HL, Horney C, Fairclough DL, Leister EC, Coors M, Capell WH, Boxer RSClinical trials (London, England)Daddato A, Wald HL, Horney C, Fairclough DL, Leister EC, Coors M, Capell WH, Boxer RS. A randomized trial of heart failure disease management in skilled nursing facilities (SNF Connect): Lessons learned. Clin Trials. 2017 Jun; 14(3):308-313.Clin Trials2017-01-31T00:00:002017A randomized trial of heart failure disease management in skilled nursing facilities (SNF Connect): Lessons learned.5Other Faculty1Professor3Asst Professor2Assoc Professor12801 E 17th Ave2RC1SResearch South Tower12801 E 17th AveAurora80045-2570CO2010-02-28NIHCAPELL, WARREN H2005-03-01Lipoprotein lipase in myocyte fuel partitioningK08DK0692912005-06-30NIHCAPELL, WARREN H2003-07-01Lipoprotein lipase in fatty acid partitioningF32DK063852Principal InvestigatorPrincipal Investigator16898578Capell WH, Eckel RHCurrent diabetes reportsCapell WH, Eckel RH. Treatment of hypertriglyceridemia. Curr Diab Rep. 2006 Jun; 6(3):230-40.Curr Diab Rep2006-06-01T00:00:002006Treatment of hypertriglyceridemia.16929366Capell WH, Eckel RHNature clinical practice. Endocrinology & metabolismCapell WH, Eckel RH. Severe hypertriglyceridemia with a history of treatment failure. Nat Clin Pract Endocrinol Metab. 2005 Nov; 1(1):53-8; quiz 59.Nat Clin Pract Endocrinol Metab2005-11-01T00:00:002005Severe hypertriglyceridemia with a history of treatment failure.Authorship 164563428630267Hess CN, Norgren L, Ansel GM, Capell WH, Fletcher JP, Fowkes FGR, Gotts?ter A, Hitos K, Jaff MR, Nordanstig J, Hiatt WRCirculationHess CN, Norgren L, Ansel GM, Capell WH, Fletcher JP, Fowkes FGR, Gotts?ter A, Hitos K, Jaff MR, Nordanstig J, Hiatt WR. A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization: A TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) Initiative. Circulation. 2017 Jun 20; 135(25):2534-2555.Circulation2017-06-20T00:00:002017A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization: A TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) Initiative.21291705Linnebur SA, Capell WH, Saseen JJ, Wolfe P, Eckel RHJournal of clinical lipidologyLinnebur SA, Capell WH, Saseen JJ, Wolfe P, Eckel RH. Plant sterols added to combination statin and colesevelam hydrochloride therapy failed to lower low-density lipoprotein cholesterol concentrations. J Clin Lipidol. 2007 Dec; 1(6):626-33.J Clin Lipidol2007-10-18T00:00:002007Plant sterols added to combination statin and colesevelam hydrochloride therapy failed to lower low-density lipoprotein cholesterol concentrations.12588776Capell WH, DeSouza CA, Poirier P, Bell ML, Stauffer BL, Weil KM, Hernandez TL, Eckel RHArteriosclerosis, thrombosis, and vascular biologyCapell WH, DeSouza CA, Poirier P, Bell ML, Stauffer BL, Weil KM, Hernandez TL, Eckel RH. Short-term triglyceride lowering with fenofibrate improves vasodilator function in subjects with hypertriglyceridemia. Arterioscler Thromb Vasc Biol. 2003 Feb 01; 23(2):307-13.Arterioscler Thromb Vasc Biol2003-02-01T00:00:002003Short-term triglyceride lowering with fenofibrate improves vasodilator function in subjects with hypertriglyceridemia.8696944Capell WH, Zambon A, Austin MA, Brunzell JD, Hokanson JEArteriosclerosis, thrombosis, and vascular biologyCapell WH, Zambon A, Austin MA, Brunzell JD, Hokanson JE. Compositional differences of LDL particles in normal subjects with LDL subclass phenotype A and LDL subclass phenotype B. Arterioscler Thromb Vasc Biol. 1996 Aug; 16(8):1040-6.Arterioscler Thromb Vasc Biol1996-08-01T00:00:001996Compositional differences of LDL particles in normal subjects with LDL subclass phenotype A and LDL subclass phenotype B.17145229Hernandez TL, Capell WH, Wolfe P, Gerard LA, Eckel RHThe American journal of cardiologyHernandez TL, Capell WH, Wolfe P, Gerard LA, Eckel RH. Time course of C-reactive protein reduction with simvastatin therapy in patients with type 2 diabetes mellitus. Am J Cardiol. 2006 Dec 15; 98(12):1656-9.Am J Cardiol2006-10-25T00:00:002006Time course of C-reactive protein reduction with simvastatin therapy in patients with type 2 diabetes mellitus.12700337Schlaepfer IR, Pulawa LK, Ferreira LD, James DE, Capell WH, Eckel RHJournal of lipid researchSchlaepfer IR, Pulawa LK, Ferreira LD, James DE, Capell WH, Eckel RH. Increased expression of the SNARE accessory protein Munc18c in lipid-mediated insulin resistance. J Lipid Res. 2003 Jun; 44(6):1174-81.J Lipid Res2003-04-16T00:00:002003Increased expression of the SNARE accessory protein Munc18c in lipid-mediated insulin resistance.20107198Hernandez TL, Sutherland JP, Wolfe P, Allian-Sauer M, Capell WH, Talley ND, Wyatt HR, Foster GD, Hill JO, Eckel RHThe American journal of clinical nutritionHernandez TL, Sutherland JP, Wolfe P, Allian-Sauer M, Capell WH, Talley ND, Wyatt HR, Foster GD, Hill JO, Eckel RH. Lack of suppression of circulating free fatty acids and hypercholesterolemia during weight loss on a high-fat, low-carbohydrate diet. Am J Clin Nutr. 2010 Mar; 91(3):578-85.Am J Clin Nutr2010-01-27T00:00:002010Lack of suppression of circulating free fatty acids and hypercholesterolemia during weight loss on a high-fat, low-carbohydrate diet.20628023Capell WH, Schlaepfer IR, Wolfe P, Watson PA, Bessesen DH, Pagliassotti MJ, Eckel RHAmerican journal of physiology. Endocrinology and metabolismCapell WH, Schlaepfer IR, Wolfe P, Watson PA, Bessesen DH, Pagliassotti MJ, Eckel RH. Fatty acids increase glucose uptake and metabolism in C2C12 myoblasts stably transfected with human lipoprotein lipase. Am J Physiol Endocrinol Metab. 2010 Oct; 299(4):E576-83.Am J Physiol Endocrinol Metab2010-07-13T00:00:002010Fatty acids increase glucose uptake and metabolism in C2C12 myoblasts stably transfected with human lipoprotein lipase.Authorship 181146129754671Capell WH, Bonaca MP, Nehler MR, Chen E, Kittelson JM, Anand SS, Berkowitz SD, Debus ES, Fanelli F, Haskell L, Patel MR, Bauersachs R, Hiatt WRAmerican heart journalCapell WH, Bonaca MP, Nehler MR, Chen E, Kittelson JM, Anand SS, Berkowitz SD, Debus ES, Fanelli F, Haskell L, Patel MR, Bauersachs R, Hiatt WR. Rationale and design for the Vascular Outcomes study of ASA along with rivaroxaban in endovascular or surgical limb revascularization for peripheral artery disease (VOYAGER PAD). Am Heart J. 2018 05; 199:83-91.Am Heart J2018-02-03T00:00:002018Rationale and design for the Vascular Outcomes study of ASA along with rivaroxaban in endovascular or surgical limb revascularization for peripheral artery disease (VOYAGER PAD).MarcBonacaMarc Peter Bonaca39.74801570000000-104.8344263000000014508Bonaca, MarcProfessorD035002Anatomy1453450.746163Lower ExtremityD001241Chemicals & Drugs1363440.798135AspirinD000069552322120.858013RivaroxabanD065427Chemicals & Drugs321410.901518Factor Xa InhibitorsD058729Disorders713980.628027Peripheral Arterial DiseaseAuthorship 203406631248598Gustavson AM, Drake C, Lakin A, Daddato AE, Falvey JR, Capell W, Lum HD, Jones CD, Unroe KT, Towsley GL, Stevens-Lapsley JE, Levy CR, Boxer RSJournal of the American Medical Directors AssociationGustavson AM, Drake C, Lakin A, Daddato AE, Falvey JR, Capell W, Lum HD, Jones CD, Unroe KT, Towsley GL, Stevens-Lapsley JE, Levy CR, Boxer RS. Conducting Clinical Research in Post-acute and Long-term Nursing Home Care Settings: Regulatory Challenges. J Am Med Dir Assoc. 2019 07; 20(7):798-803.J Am Med Dir Assoc2019-07-01T00:00:002019Conducting Clinical Research in Post-acute and Long-term Nursing Home Care Settings: Regulatory Challenges.SOM-MEDSOM-SRGEndocrinologyVS ClinicalCardiologyUniversity of Colorado Denver - Anschutz Medical CampusMarkNehlerMark Richard Nehler39.74403280000000-104.840810400000001235Nehler, MarkProfessor2.354010.00737139161research areas4.121750.019993125coauthor of124.4924.5842260similar to1131selected publicationsVirginiaSarapuraVirginia Sarapura39.74389450000000-104.83943520000000173Sarapura, VirginiaProfessorTaniaReisTania Reis39.74389450000000-104.839435200000004172Reis, TaniaAssociate ProfessorAngelaGrantAngela Grant39.74389450000000-104.839435200000006125Grant, AngelaAffiliateBryanHaugenBryan R Haugen39.74389450000000-104.83943520000000776Haugen, BryanProfessorAuthorship 218047832222135Bonaca MP, Bauersachs RM, Anand SS, Debus ES, Nehler MR, Patel MR, Fanelli F, Capell WH, Diao L, Jaeger N, Hess CN, Pap AF, Kittelson JM, Gudz I, M?ty?s L, Krievins DK, Diaz R, Brodmann M, Muehlhofer E, Haskell LP, Berkowitz SD, Hiatt WRThe New England journal of medicineBonaca MP, Bauersachs RM, Anand SS, Debus ES, Nehler MR, Patel MR, Fanelli F, Capell WH, Diao L, Jaeger N, Hess CN, Pap AF, Kittelson JM, Gudz I, M?ty?s L, Krievins DK, Diaz R, Brodmann M, Muehlhofer E, Haskell LP, Berkowitz SD, Hiatt WR. Rivaroxaban in Peripheral Artery Disease after Revascularization. N Engl J Med. 2020 05 21; 382(21):1994-2004.N Engl J Med2020-03-28T00:00:002020Rivaroxaban in Peripheral Artery Disease after Revascularization.Authorship 231039733138628Hiatt WR, Bonaca MP, Patel MR, Nehler MR, Debus ES, Anand SS, Capell WH, Brackin T, Jaeger N, Hess CN, Pap AF, Berkowitz SD, Muehlhofer E, Haskell L, Brasil D, Madaric J, Sillesen H, Szalay D, Bauersachs RCirculationHiatt WR, Bonaca MP, Patel MR, Nehler MR, Debus ES, Anand SS, Capell WH, Brackin T, Jaeger N, Hess CN, Pap AF, Berkowitz SD, Muehlhofer E, Haskell L, Brasil D, Madaric J, Sillesen H, Szalay D, Bauersachs R. Rivaroxaban and Aspirin in Peripheral Artery Disease Lower Extremity Revascularization: Impact of Concomitant Clopidogrel on Efficacy and Safety. Circulation. 2020 12 08; 142(23):2219-2230.Circulation2020-11-03T00:00:002020Rivaroxaban and Aspirin in Peripheral Artery Disease Lower Extremity Revascularization: Impact of Concomitant Clopidogrel on Efficacy and Safety.MichaelSzarekMichael Jon Szarek17383Szarek, Michael0000-0002-0046-0264Professor-ResearchAuthorship 2346901Authorship 2354611Authorship 236390233463078Capell WH, Wynia MK, Hurley EA, Bonaca MPEthics & human researchCapell WH, Wynia MK, Hurley EA, Bonaca MP. Should Participants in Clinical Trials Be Able to Withdraw from Passive Follow-Up? Ethics Hum Res. 2021 Jan; 43(1):32-36.Ethics Hum Res2021-01-01T00:00:002021Should Participants in Clinical Trials Be Able to Withdraw from Passive Follow-Up?33577800Capell WH, Barnathan ES, Piazza G, Spyropoulos AC, Hsia J, Bull S, Lipardi C, Sugarmann C, Suh E, Rao JP, Hiatt WR, Bonaca MPAmerican heart journalCapell WH, Barnathan ES, Piazza G, Spyropoulos AC, Hsia J, Bull S, Lipardi C, Sugarmann C, Suh E, Rao JP, Hiatt WR, Bonaca MP. Rationale and design for the study of rivaroxaban to reduce thrombotic events, hospitalization and death in outpatients with COVID-19: The PREVENT-HD study. Am Heart J. 2021 05; 235:12-23.Am Heart J2021-02-09T00:00:002021Rationale and design for the study of rivaroxaban to reduce thrombotic events, hospitalization and death in outpatients with COVID-19: The PREVENT-HD study.33665516Biswas MP, Capell WH, McDermott MM, Jacobs DL, Beckman JA, Bonaca MP, Hiatt WRJACC. Basic to translational scienceBiswas MP, Capell WH, McDermott MM, Jacobs DL, Beckman JA, Bonaca MP, Hiatt WR. Exercise Training and Revascularization in the Management of Symptomatic Peripheral Artery Disease. JACC Basic Transl Sci. 2021 Feb; 6(2):174-188.JACC Basic Transl Sci2021-02-22T00:00:002021Exercise Training and Revascularization in the Management of Symptomatic Peripheral Artery Disease.Authorship 2406531034010631Bauersachs RM, Szarek M, Brodmann M, Gudz I, Debus ES, Nehler MR, Anand SS, Patel MR, Hess CN, Capell WH, Rogers K, Muehlhofer E, Haskell LP, Berkowitz SD, Hiatt WR, Bonaca MPJournal of the American College of CardiologyBauersachs RM, Szarek M, Brodmann M, Gudz I, Debus ES, Nehler MR, Anand SS, Patel MR, Hess CN, Capell WH, Rogers K, Muehlhofer E, Haskell LP, Berkowitz SD, Hiatt WR, Bonaca MP. Total Ischemic Event Reduction With Rivaroxaban After Peripheral Arterial Revascularization in the VOYAGER PAD?Trial. J Am Coll Cardiol. 2021 07 27; 78(4):317-326.J Am Coll Cardiol2021-05-16T00:00:002021Total Ischemic Event Reduction With Rivaroxaban After Peripheral Arterial Revascularization in the VOYAGER PAD?Trial.ScottBerkowitzScott Darrell Berkowitz19131Berkowitz, ScottProfessor-ClinicalAuthorship 2454048Authorship 25118413Authorship 2461818Authorship 250802734380322Debus ES, Nehler MR, Govsyeyev N, Bauersachs RM, Anand SS, Patel MR, Fanelli F, Capell WH, Brackin T, Hinterreiter F, Krievins D, Nault P, Piffaretti G, Svetlikov A, Jaeger N, Hess CN, Sillesen HH, Conte M, Mills J, Muehlhofer E, Haskell LP, Berkowitz SD, Hiatt WR, Bonaca MPCirculationDebus ES, Nehler MR, Govsyeyev N, Bauersachs RM, Anand SS, Patel MR, Fanelli F, Capell WH, Brackin T, Hinterreiter F, Krievins D, Nault P, Piffaretti G, Svetlikov A, Jaeger N, Hess CN, Sillesen HH, Conte M, Mills J, Muehlhofer E, Haskell LP, Berkowitz SD, Hiatt WR, Bonaca MP. Effect of Rivaroxaban and Aspirin in Patients With Peripheral Artery Disease Undergoing Surgical Revascularization: Insights From the VOYAGER PAD Trial. Circulation. 2021 10 05; 144(14):1104-1116.Circulation2021-08-12T00:00:002021Effect of Rivaroxaban and Aspirin in Patients With Peripheral Artery Disease Undergoing Surgical Revascularization: Insights From the VOYAGER PAD Trial.34430972Krantz MJ, Debus SE, Hsia J, Patel MR, Anand SS, Nehler MR, Hess CN, Capell WH, Bracken T, Szarek M, M?ty?s L, Krievins DK, Nault P, Stefanov S, Haskell LP, Berkowitz SD, Muehlhofer E, Hiatt WR, Bauersachs RM, Bonaca MPEuropean heart journalKrantz MJ, Debus SE, Hsia J, Patel MR, Anand SS, Nehler MR, Hess CN, Capell WH, Bracken T, Szarek M, M?ty?s L, Krievins DK, Nault P, Stefanov S, Haskell LP, Berkowitz SD, Muehlhofer E, Hiatt WR, Bauersachs RM, Bonaca MP. Low-dose rivaroxaban plus aspirin in older patients with peripheral artery disease undergoing acute limb revascularization: insights from the VOYAGER PAD trial. Eur Heart J. 2021 10 14; 42(39):4040-4048.Eur Heart J2021-10-14T00:00:002021Low-dose rivaroxaban plus aspirin in older patients with peripheral artery disease undergoing acute limb revascularization: insights from the VOYAGER PAD trial.34637332Hess CN, Debus ES, Nehler MR, Anand SS, Patel MR, Szarek M, Capell WH, Hsia J, Beckman JA, Brodmann M, Diaz R, Habertheuer P, Leeper NJ, Powell RJ, Sillesen H, Muehlhofer E, Berkowitz SD, Haskell LP, Bauersachs RM, Bonaca MPCirculationHess CN, Debus ES, Nehler MR, Anand SS, Patel MR, Szarek M, Capell WH, Hsia J, Beckman JA, Brodmann M, Diaz R, Habertheuer P, Leeper NJ, Powell RJ, Sillesen H, Muehlhofer E, Berkowitz SD, Haskell LP, Bauersachs RM, Bonaca MP. Reduction in Acute Limb Ischemia With Rivaroxaban Versus Placebo in Peripheral Artery Disease After Lower Extremity Revascularization: Insights From VOYAGER PAD. Circulation. 2021 12 07; 144(23):1831-1841.Circulation2021-10-12T00:00:002021Reduction in Acute Limb Ischemia With Rivaroxaban Versus Placebo in Peripheral Artery Disease After Lower Extremity Revascularization: Insights From VOYAGER PAD.34711335Hess CN, Patel MR, Bauersachs RM, Anand SS, Debus ES, Nehler MR, Fanelli F, Yeh RW, Secemsky EA, Beckman JA, Mauri L, Govsyeyev N, Capell WH, Brackin T, Berkowitz SD, Muehlhofer E, Haskell LP, Hiatt WR, Bonaca MPJournal of the American College of CardiologyHess CN, Patel MR, Bauersachs RM, Anand SS, Debus ES, Nehler MR, Fanelli F, Yeh RW, Secemsky EA, Beckman JA, Mauri L, Govsyeyev N, Capell WH, Brackin T, Berkowitz SD, Muehlhofer E, Haskell LP, Hiatt WR, Bonaca MP. Safety and Effectiveness of Paclitaxel Drug-Coated Devices in Peripheral Artery?Revascularization: Insights From VOYAGER PAD. J Am Coll Cardiol. 2021 11 02; 78(18):1768-1778.J Am Coll Cardiol2021-11-02T00:00:002021Safety and Effectiveness of Paclitaxel Drug-Coated Devices in Peripheral Artery?Revascularization: Insights From VOYAGER PAD.Authorship 255283234986394Hess CN, Capell WH, Bristow MR, Ruf W, Szarek M, Morrow DA, Nicolau JC, Graybill CA, Marshall D, Hsia J, Bonaca MPAmerican heart journalHess CN, Capell WH, Bristow MR, Ruf W, Szarek M, Morrow DA, Nicolau JC, Graybill CA, Marshall D, Hsia J, Bonaca MP. Rationale and design of a study to assess the safety and efficacy of rNAPc2 in COVID-19: the Phase 2b ASPEN-COVID-19 trial. Am Heart J. 2022 04; 246:136-143.Am Heart J2022-01-02T00:00:002022Rationale and design of a study to assess the safety and efficacy of rNAPc2 in COVID-19: the Phase 2b ASPEN-COVID-19 trial.Authorship 257658835170216Berkowitz SD, Bauersachs RM, Szarek M, Nehler MR, Debus ES, Patel MR, Anand SS, Capell WH, Hess CN, Hsia J, Leeper NJ, Brasil D, M?ty?s L, Diaz R, Brodmann M, Muehlhofer E, Haskell LP, Bonaca MPJournal of thrombosis and haemostasis : JTHBerkowitz SD, Bauersachs RM, Szarek M, Nehler MR, Debus ES, Patel MR, Anand SS, Capell WH, Hess CN, Hsia J, Leeper NJ, Brasil D, M?ty?s L, Diaz R, Brodmann M, Muehlhofer E, Haskell LP, Bonaca MP. Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone. J Thromb Haemost. 2022 05; 20(5):1193-1205.J Thromb Haemost2022-03-07T00:00:002022Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone.Authorship 263696835699170Hess CN, Baumgartner I, Anand SS, Nehler MR, Patel MR, Debus ES, Szarek M, Capell W, Muehlhofer E, Berkowitz SD, Haskell LP, Bauersachs RM, Bonaca MP, Hsia JJournal of the American Heart AssociationHess CN, Baumgartner I, Anand SS, Nehler MR, Patel MR, Debus ES, Szarek M, Capell W, Muehlhofer E, Berkowitz SD, Haskell LP, Bauersachs RM, Bonaca MP, Hsia J. Sex-Based Differences in Outcomes Following Peripheral Artery Revascularization: Insights From VOYAGER PAD. J Am Heart Assoc. 2022 06 21; 11(12):e024655.J Am Heart Assoc2022-06-14T00:00:002022Sex-Based Differences in Outcomes Following Peripheral Artery Revascularization: Insights From VOYAGER PAD.Authorship 263830835731517Hess CN, Szarek M, Anand SS, Bauersachs RM, Patel MR, Debus ES, Nehler MR, Capell WH, Beckman JA, Piazza G, Henkin S, Bura-Rivi?re A, Lawall H, Roztocil K, Hsia J, Muehlhofer E, Berkowitz SD, Haskell LP, Bonaca MPJAMA network openHess CN, Szarek M, Anand SS, Bauersachs RM, Patel MR, Debus ES, Nehler MR, Capell WH, Beckman JA, Piazza G, Henkin S, Bura-Rivi?re A, Lawall H, Roztocil K, Hsia J, Muehlhofer E, Berkowitz SD, Haskell LP, Bonaca MP. Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity Revascularization. JAMA Netw Open. 2022 06 01; 5(6):e2215580.JAMA Netw Open2022-06-01T00:00:002022Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity Revascularization.Authorship 2724322136470531Govsyeyev N, Nehler M, Conte MS, Debus S, Chung J, Dorigo W, Gudz I, Krievins D, Mills J, Moll F, Norgren L, Piffaretti G, Powell R, Szalay D, Sillesen H, Wohlauer M, Szarek M, Bauersachs RM, Anand SS, Patel MR, Capell WH, Jaeger N, Hess CN, Muehlhofer E, Haskell LP, Berkowitz SD, Bonaca MPJournal of vascular surgeryGovsyeyev N, Nehler M, Conte MS, Debus S, Chung J, Dorigo W, Gudz I, Krievins D, Mills J, Moll F, Norgren L, Piffaretti G, Powell R, Szalay D, Sillesen H, Wohlauer M, Szarek M, Bauersachs RM, Anand SS, Patel MR, Capell WH, Jaeger N, Hess CN, Muehlhofer E, Haskell LP, Berkowitz SD, Bonaca MP. Rivaroxaban in patients with symptomatic peripheral artery disease after lower extremity bypass surgery with venous and prosthetic conduits. J Vasc Surg. 2023 04; 77(4):1107-1118.e2.J Vasc Surg2022-12-05T00:00:002022Rivaroxaban in patients with symptomatic peripheral artery disease after lower extremity bypass surgery with venous and prosthetic conduits.Authorship 2834121037381988Hess CN, Hsia J, Carroll IA, Nehler MR, Ruf W, Morrow DA, Nicolau JC, Berwanger O, Szarek M, Capell WH, Johri S, Pursley MS, Gupta R, Meehan PS, Franchi F, Effron MB, Marshall D, Graybill CA, Huebler SP, Keuer T, Bristow MR, Bonaca MPArteriosclerosis, thrombosis, and vascular biologyHess CN, Hsia J, Carroll IA, Nehler MR, Ruf W, Morrow DA, Nicolau JC, Berwanger O, Szarek M, Capell WH, Johri S, Pursley MS, Gupta R, Meehan PS, Franchi F, Effron MB, Marshall D, Graybill CA, Huebler SP, Keuer T, Bristow MR, Bonaca MP. Novel Tissue Factor Inhibition for Thromboprophylaxis in COVID-19: Primary Results of the ASPEN-COVID-19 Trial. Arterioscler Thromb Vasc Biol. 2023 08; 43(8):1572-1582.Arterioscler Thromb Vasc Biol2023-06-29T00:00:002023Novel Tissue Factor Inhibition for Thromboprophylaxis in COVID-19: Primary Results of the ASPEN-COVID-19 Trial.true1ProfessorProfessortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1Associate ProfessorAssociate Professortrue1Professor-ClinicalProfessor-Clinicaltrue1Professor-ResearchProfessor-Researchtrue1ProfessorProfessortrue1ProfessorProfessortrue1AffiliateAffiliatetrue1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1Asst ProfessorAsst Professor23689355Wang H, Capell W, Yoon JH, Faubel S, Eckel RHInternational journal of obesity (2005)Wang H, Capell W, Yoon JH, Faubel S, Eckel RH. Obesity development in caspase-1-deficient mice. Int J Obes (Lond). 2014 Jan; 38(1):152-5.Int J Obes (Lond)2013-04-24T00:00:002013Obesity development in caspase-1-deficient mice.